2026HIV and AgingStudiesHIV acquisitions, safety, and pharmacokinetics of lenacapavir for HIV pre-exposure prophylaxis in pregnant and lactating women (PURPOSE 1): a substudy of a phase 3, randomised controlled trialPURPOSE 1 LEN Pregnancy publication_Lancet HIV_July 2026
